Title: Antiviral Drugs Market to Clock US$82.9 bn by 2024, Rise in Number of FDA approval to Fuel Market’s Growth
1Antiviral Drugs Market
- Antiviral Drugs Market Segmentation by Disease
Indication - Hepatitis Virus Infection, HIV
Infection, and Respiratory Virus Infection
Product Type - Branded Drugs and Generic Drugs
Distribution Channels - Hospital Pharmacy Store,
Retail Pharmacy Store, and Online Pharmacy, and
Forecast, 2016 - 2024
2019 Transparency Market Research, All Rights
Reserved
2Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Global Antiviral Drugs Market Analysis and Forecasts, By Software Type
Chapter 6 Global Antiviral Drugs Market Analysis, by Modality
Chapter 7 Global Antiviral Drugs Market Analysis, by Application
Chapter 8 Global Antiviral Drugs Market Analysis, by End-user
Chapter 9 Global Antiviral Drugs Market Analysis and Forecast by Region
Chapter 10 Europe Antiviral Drugs Market Analysis and Forecast
Chapter 11 Asia Pacific Antiviral Drugs Market Analysis and Forecast
Chapter 12 Latin America Antiviral Drugs Market Analysis and Forecast
Chapter 13 Middle East Africa Antiviral Drugs Market Analysis and Forecast
Chapter 14 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3Antiviral Drugs Market - Snapshot
- Antiviral drugs refer to those prescription
medicines that are capable of fighting against
flu viruses in ones body. - Antiviral drugs could include intravenous
solutions, an inhaled powder, liquid, or pills. - The global antiviral drugs market is likely to
observe considerable growth due to the rising
incidences of viral infections. - As coronavirus spreads at an exponential rate and
the number of deaths crosses 74,000 worldwide,
efforts are being made to lessen transmission
through standard public health interventions.
These interventions are based on tracing of
contacts and isolation of cases. - So far, there is no drug or vaccine to contain
the spread of the pandemic worldwide.
2019 Transparency Market Research, All Rights
Reserved
4(No Transcript)
5Reports Highlights
- The global antiviral drugs market will exhibit a
healthy CAGR of 6.40 during the forecast period
of 2016 to 2024. - The global antiviral drugs market is projected to
rise at a significant pace in the coming few
years. - Availability of strong product pipeline is
another factor expected to propel the growth of
the global antiviral drugs market in the coming
years. - As per a study, over 36 million people around
the globe are suffering from HIV infection in
2014. Further, the population in the region
touched 2.0 million new cases of HIV.
2019 Transparency Market Research, All Rights
Reserved
6Continue..
- Researchers and doctors have observed that
antiviral drugs administered shortly after the
onset of symptoms can diminish the infectiousness
to others through diminished viral shredding in
the patients respiratory secretions. - Growing prevalence of viral diseases such as
malaria, dengue, chikungunya, and other deadly
viral diseases is prompting an ever increasing
demand for these antiviral drugs from these
regions. - Some of the key players in the global antiviral
drugs market include names such as Merck Co.
Inc., Johnson and Johnson, Schering-Plough
Corporation, AbbVie Inc., and AstraZeneca Plc.
among others.
2019 Transparency Market Research, All Rights
Reserved
7Contact
- To know more about us, please visit our website
- www.transparencymarketresearch.com
- For sales queries or new topics email us on
- sales_at_transparencymarketresearch.com
- Thank You
2019 Transparency Market Research, All Rights
Reserved